News Agency
The Times Real Estate

Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy

  • Written by PR Newswire
Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO® (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy

– Based on Results from Phase 3 BOSTON Study, Marketing Authorisation Expands Multiple Myeloma Indication –

– Approval Follows Positive Opinion by European Committee for Medicinal Products for Human Use (CHMP) in May 2022

NEWTON, Mass. and FLORENCE, Italy, July 21, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc....

Read more: Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission...

A Guide to Safe and Legal Asbestos Disposal

Asbestos disposal requires strict adherence to safety and legal standards. This hazardous material poses severe health risks. Handle it with care. It's vital to know the rules, health risks, and pros. They are essential to safe asbestos removal and disposal. Why... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion